Navigation Links
Treating Childhood Leukemia With Fewer Side Effects
Date:9/10/2009

Dutch researchers skip radiation treatments, some chemo but add corticosteroid

THURSDAY, Sept. 10 (HealthDay News) -- Adding the corticosteroid dexamethasone to the treatment regimen of children with acute lymphoblastic leukemia improves survival rates and reduces the incidence of the cancer recurring, a new Dutch study shows.

Acute lymphoblastic leukemia (ALL), a cancer of the blood, is the most common childhood cancer and is highly treatable, according to background information in the study.

But the researchers say that many children with ALL are over-treated with cranial radiation and chemotherapy drugs that cause significant side effects and may not be necessary to cure them.

The study found that a dexamethasone-based treatment can improve the cancer cure rate and reduce the risk of relapse without radiation and routinely used chemotherapy drugs. The findings were published online Sept. 9 The Lancet Oncology.

Dexamethasone is sold under the brand name Decadron.

The study involved 859 youths, aged 1 to 18, with ALL. About 30 percent of them were considered to be at high risk for recurrence.

Participants not at high risk were given a basic three-drug induction (dexamethasone, vincristine and L-asparaginase) and medium-dose methotrexate. High-risk youths were given a four-drug induction (the same three drugs as the others got plus four doses of daunorubicin), consolidation with methotrexate and two intensification courses before maintenance, which was 109 weeks for all participants.

Triple intrathecal chemo was given 13 times in those not at high risk, 15 times in high-risk youths and 17 times in those with initial central nervous system involvement. No one was given cranial radiation.

Five-year, cancer-free survival for the high-risk group was 72 percent, the study found. Those not at high risk had an 84 percent survival rate. About 70 percent of all pe
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

1

GOOD

Page: 1 2

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
3. Treating diabetes during pregnancy can break link to childhood obesity
4. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
5. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
6. Family-based treatment more effective than supportive psychotherapy in treating bulimia
7. Treating depression may improve recovery of heart rate variability following coronary syndromes
8. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
9. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
10. Stem cells show promise for treating Huntingtons disease
11. Treating obstructive sleep apnea, preventing heart attacks and strokes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treating Childhood Leukemia With Fewer Side Effects
Treating Childhood Leukemia With Fewer Side Effects
(Date:12/15/2009)... and SUNNYVALE, Calif., Dec. 15 ... Information Technology and Managed Services, and Ruckus ... (WLAN) solutions provider, today announce their partnership ... interference avoidance technology. ,, The collaboration will ... with Ruckus, cutting-edge Wi-Fi solutions, including its ...
(Date:12/15/2009)... and money with comprehensive solution , ... ... Epocrates, Inc., developer of the most popular medical application ... premium software suite for the platform – Epocrates® Essentials ... on Epocrates products on their iPhone and iPod touch devices ...
(Date:12/15/2009)... the most caring, conscientious practice you have ever been a part ... of Dallas, we can help to achieve this goal and meet ... ... 2009 -- The Dermatology Center of Dallas, a Dallas based, full-service ... Beth “J.B.” Foshee, MD in their practice. Dr. Foshee joins ...
(Date:12/15/2009)... ... (PRWEB) December 10, 2009 -- Millions of men and women suffer from ... of red, blue or purple veins that spider-web across the nose, cheeks, ... it’s been estimated that 25-30% of women and 10-20% of men suffer ... Veinwave has been available for over 8 years in Europe (where ...
(Date:12/15/2009)... Westchester, Ill. A study in the Dec. ... Sleep Medicine indicates that significant associations exist ... gastrointestinal regurgitation and headaches in young school-aged children. ... that parent-reported insomnia was 3.3 times more likely ... more likely in children with headaches. Nineteen ...
Breaking Medicine News(10 mins):Health News:Atrion Networking Corporation Selects Ruckus Wireless for 'Reliable as Wire' Enterprise Wi-Fi Service 2Health News:Atrion Networking Corporation Selects Ruckus Wireless for 'Reliable as Wire' Enterprise Wi-Fi Service 3Health News:Epocrates Expands iPhone Offerings with New Premium Content 2Health News:Epocrates Expands iPhone Offerings with New Premium Content 3Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3
... broad range of imaging solutions to cardiologyORLANDO, Fla., March ... ) provides imaging excellence and workflow enhancements for cardiology ... Session of the American College of Cardiology (ACC) from ... at the Siemens booth at this year,s conference is ...
... UpSpring Baby (TM) executives, Lisa Williamson and Julie Jumonville, ... agreements with new and existing investors to raise gross ... for the innovative parent and baby products company based ... used for new product development and sales support as ...
... as treatment target against disease progression , , ... identified marker for prostate cancer progression may also ... Michigan researchers say. , Previous research has found ... linked with neoplastic progression in prostate cancer. However, ...
... Document Management with Electronic Medical Record Systems ... Meet HIPAA Regulatory RequirementsPROVO, Utah, March 25 ... of its electronic document management (EDM) ... Practice Management (PM) systems which are used by ...
... NovaLign(TM) Orthopaedics, Inc., formerly known as OsteoLign, Inc., ... and Drug Administration to market its Intramedullary Fixation System, ... treatment of long bone fractures, including the humerus, tibia ... enter the intramedullary fracture fixation market, estimated to be ...
... plan to leverage Health Integrated,s Synergy Targeted Population ... health for Medicaid subscribersPORTLAND, Ore. and TAMPA, Fla., ... that provides Medicaid and Medicare managed care services ... Population Health Management company, are partnering to improve ...
Other Medicine News:Health News:Siemens Highlights Its Ultimate Hybrid System at ACC 2009 2Health News:Siemens Highlights Its Ultimate Hybrid System at ACC 2009 3Health News:Siemens Highlights Its Ultimate Hybrid System at ACC 2009 4Health News:Siemens Highlights Its Ultimate Hybrid System at ACC 2009 5Health News:Female Entrepreneurs Secure $4M in New Financing for UpSpring Baby 2Health News:eFileCabinet Helps Medical Offices Realize Full Benefits of Electronic Medical Record Systems 2Health News:NovaLign(TM) Orthopaedics, Inc. Announces its First 510(K) Clearance From the FDA for New Intramedullary Fixation System 2Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 2Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 3
(Date:12/14/2009)... a statement by Linda A. Suydam, D.P.A., president ... today,s release of the National Institute on Drug ... released today on this year,s Monitoring the Future ... to educate and empower parents with the information ... medicine abuse. The Consumer Healthcare Products Association (CHPA) ...
(Date:12/14/2009)... board of directors of Eli Lilly and Company (NYSE: ... the first quarter of 2010 of $0.49 a share ... is payable March 10, 2010 to shareholders of record ... 12, 2010. ,, Lilly, a leading innovation-driven corporation, is ... the latest research from its own worldwide laboratories and ...
(Date:12/14/2009)... Cardinal Health today announced that executives of ... ,, Goldman Sachs CEO Unplugged Conference ... Sachs Conference Center in New York. 28th ... at Noon EST at the Westin St. Francis Hotel ... executives will discuss Cardinal Health,s diverse products and services, ...
Breaking Medicine Technology:Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Cardinal Health Executives to Speak at Two Investor Events in January 2Darwins Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable June 3 2009 47693 1Darwins Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable June 3 2009 47693 2Darwins Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable June 3 2009 47693 3A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 47690 1A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 47690 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 1Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 3
... company,s third to enter human trials in 2 years, ... that the U.S. Food and Drug Administration has approved ... hypertension,drug. With the approval, Addrenex has launched a phase ... for hypertension., The phase 2 trial is a ...
... October 23 , - First Responses in ... key role in cell duplication and are,implicated in ... of tumour. A,lecture focusing on Aurora kinase inhibitors ... the 20th EORTC-NCI-AACR Symposium "Molecular,Targets and Cancer Therapeutics" ...
Other Medicine Technology:Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415 2Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 2Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: